Influenza A and B IgG seropositivity and coronary atherosclerosis assessed by angiography.

Infectious agents, in particular intracellular pathogens that can establish long-term, persistent seropositivity, may play an important role in atherogenesis. The possible association between influenza type A and B infection and angiographically proven coronary artery disease (CAD) and the effect of the aggregate pathogen burden on CAD was studied by testing blood from 218 patients undergoing coronary angiography for serum IgG antibodies to influenza A and B, and for antibodies to four other pathogens (hepatitis A, Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus). This analysis demonstrates that although influenza (A and B) seropositivity represents no predictor of risk for CAD, infectious burden is independently associated with coronary atherosclerosis.

[1]  Jeffrey L. Anderson,et al.  Chronic infection and coronary artery disease. , 2003, Cardiology clinics.

[2]  S. Blankenberg,et al.  Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease , 2001, Circulation.

[3]  A. Shor.  A pathologist's view of organisms and human atherosclerosis. , 2001, The Journal of infectious diseases.

[4]  D. Shih,et al.  HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[5]  M. Naghavi,et al.  Association of Influenza Vaccination and Reduced Risk of Recurrent Myocardial Infarction , 2000, Circulation.

[6]  A. Quyyumi,et al.  Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. , 1999, Journal of the American College of Cardiology.

[7]  Jianhui Zhu,et al.  Infection and atherosclerosis: emerging mechanistic paradigms. , 1999, Circulation.

[8]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[9]  P. Ridker,et al.  Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. , 1998, Circulation.

[10]  F. Nieto.  Infections and atherosclerosis: new clues from an old hypothesis? , 1998, American journal of epidemiology.

[11]  A. Gasbarrini,et al.  Association of virulent Helicobacter pylori strains with ischemic heart disease. , 1998, Circulation.

[12]  G. Smith,et al.  Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT , 1998, The Lancet.

[13]  M. Nieminen,et al.  Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Muller,et al.  Infections prior to acute myocardial infarction onset , 1998 .

[15]  W. Kannel,et al.  Overview of atherosclerosis. , 1998, Clinical therapeutics.

[16]  P. Libby,et al.  Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. , 1997, Circulation.

[17]  D. Gemsa,et al.  Expression of transcription factor genes after influenza A virus infection. , 1997, Immunobiology.

[18]  M. Law,et al.  Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study , 1997, BMJ.

[19]  I. Fong,et al.  Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. , 1997, Circulation.

[20]  R. Zachoval,et al.  Low lipoprotein (a) levels during acute viral hepatitis , 1996, Hepatology.

[21]  J. Sanderson,et al.  Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. , 1996, Heart.

[22]  D. Strachan,et al.  Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. , 1996, Heart.

[23]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[24]  A. Folsom,et al.  Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. , 1996, Journal of clinical epidemiology.

[25]  H. Sacks,et al.  The Efficacy of Influenza Vaccine in Elderly Persons , 1995, Annals of Internal Medicine.

[26]  D Kromhout,et al.  Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. , 1995, JAMA.

[27]  D. Strachan,et al.  Fibrinogen: a link between chronic infection and coronary heart disease , 1994, The Lancet.

[28]  D. Strachan,et al.  Relation of Helicobacter pylori infection and coronary heart disease. , 1994, British heart journal.

[29]  J. Lave,et al.  Impact of Medicare reimbursement on influenza vaccination rates in the elderly. , 1994, Preventive medicine.

[30]  A. Folsom,et al.  Cytomegalovirus/herpesvirus and carotid atherosclerosis: The aric study , 1994, Journal of medical virology.

[31]  A. Folsom,et al.  Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1993, The American journal of medicine.

[32]  D. Ratcliffe,et al.  Characterization of influenza virus-induced leukocyte adherence to human umbilical vein endothelial cell monolayers. , 1993, Journal of immunology.

[33]  M. Leinonen,et al.  Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study , 1992, Annals of Internal Medicine.

[34]  H. Friedman,et al.  Viral activation of the coagulation cascade: Molecular interactions at the surface of infected endothelial cells , 1990, Cell.

[35]  M. Kazatchkine,et al.  Membrane-bound hemagglutinin mediates antibody and complement-dependent lysis of influenza virus-treated human platelets in autologous serum. , 1984, The Journal of clinical investigation.

[36]  D. Spodick,et al.  Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. , 1984, The American journal of cardiology.

[37]  M. Debakey,et al.  CYTOMEGALOVIRUS ANTIGEN WITHIN HUMAN ARTERIAL SMOOTH MUSCLE CELLS , 1983, The Lancet.

[38]  R. Ramphal,et al.  Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. , 1980, Infection and immunity.

[39]  D. Bainton,et al.  Influenza and ischaemic heart disease--a possible trigger for acute myocardial infarction? , 1978, International journal of epidemiology.

[40]  D. Mckie.  Editorial: Where the axe is falling. , 1974, Lancet.

[41]  M. P. Judkins,et al.  Selective Coronary Arteriography , 1967 .

[42]  D. Danon,et al.  Mixed Agglutination of Human Platelets and Red Cells by Influenza Virus in Vitro. Phase‐Contrast and Electronmicroscopical Observations , 1959, Vox sanguinis.

[43]  B. Brodie,et al.  A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. , 1952, The Journal of biological chemistry.

[44]  S. D. Collins.  Excess Mortality from Causes other than Influenza and Pneumonia during Influenza Epidemics. , 1932 .